CDx Diagnostics today announced that in the continued evolution of the WATS3D test as a tool in the fight against esophageal cancer, Dr. Sidney Olefson of Prima CARE, a leading healthcare practice ...

The goal is to reduce the incidence of esophageal cancer (EAC). EAC is a rare type of cancer with a high-morality rate-the cause of 2.6% of all cancer deaths nationally-and is more common in men ...

“With EAC being the leading esophageal cancer type in the U.S., there is an urgent need to apply these markers in a large-scale screening study to assess whether the test can improve detection ...